the value of axi-cel as a second-line treatment in r/r lbcl
Published 3 months ago • 40 plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
1:43
approval of exa-cel for scd
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
2:12
updates from icaria-mm: longer-term efficacy data on the combination of isa-pd in r/r myeloma
-
2:41
an overview of the latest advances in hematology
-
14:00
ayala health unit aims to lower costs of cancer treatment | early edition
-
6:24
indiko biochemistry analyzer demonstration
-
31:48
how to update avcs. video 2/ part 4 - enc&ecdis. các lưu ý khi không thể update enc
-
0:45
difference between quality of life & patient-reported outcomes
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
0:58
first-in-human trial of cln-978, a novel cd19 bispecific antibody, for the treatment of r/r b-nhl
-
4:06
lymphoma cellular therapy update
-
3:09
treatment strategies for chl patients after auto-hsct
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
2:14
addressing the high rate of disease relapse following allosct in patients with aml
-
2:49
results of a phase i trial investigating cynk-001, a placental nk-cell product, in patients with aml
-
5:21
chemo-free regimens in lymphoma
-
1:51
unmet needs in follicular lymphoma
-
10:41
trial updates in follicular lymphoma from ash 2019
-
1:52
impact of immunotherapy on lymphoma